Updated: May 30th 2021 — Notice of Annual General Meeting 2021
OSLO/LONDON, MAY 25th 2021
UPDATE: MAY 30th 2021 : The deadline from received proxies or votes is extended to 31 May at 12:00 CET.
The Annual General Meeting of EXACT Therapeutics AS will be held on 1 June 2021 at 1300hrs CET. Please find attached the notice of Annual General Meeting with attendance/Proxy, including the Board of Directors' proposed resolutions for the items listed on the agenda. The documents are also available at www.exact-tx.com
Due to the COVID-19 situation the Company’s office is closed and the Annual General Meeting will be held by proxy or by submitting votes in advance. Shareholders who notify the company will be invited to participate in a Microsoft Teams meeting, but votes need to be cast in advance. The deadline for receiving proxies or votes is 30 May 2021 at 12:00 CET. The Annual General Meeting will be efficiently carried through by strictly keeping to the agenda items.
For more information, please contact:
Masha Stromme
Chair of the Board
+47 930 22 509
About EXACT-Tx
EXACT-Tx is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.comwww.exact-tx.comwww.exact-tx.comwww.exact-tx.com